Astrocyte Announces Initiation of First-In-Human Phase 1 Study of the Promising Stroke and Traumatic Brain Injury Therapeutic, AST-004

GROTON, Conn.–(BUSINESS WIRE)–Astrocyte Pharmaceuticals Inc., a drug discovery and development company advancing novel cerebroprotective therapeutics for patients with brain injuries, announced that the Company’s first-in-human Phase 1 clinical study initiated today with the dosing of a first subject with AST-004. The promising investigational therapeutic, AST-004, is being advanced as a potential acute treatment for stroke … [Read more…]

Walgreens and Greater Than AIDS Partner with Health Departments and Community Organizations to Provide Free HIV Testing and Information in More Than 250 Cities on National HIV Testing Day (June 27)

Largest Coordinated HIV Testing Event in the Nation DEERFIELD, Ill. & SAN FRANCISCO–(BUSINESS WIRE)–Walgreens and Greater Than AIDS, a public information initiative of KFF (Kaiser Family Foundation), are teaming up with health departments and community organizations in more than 250 cities to host the largest coordinated National HIV Testing Day (NHTD) event in the nation. … [Read more…]

Pear Therapeutics Announces Three New Board Members

New Board Members Paul Mango, Shiva Rajaraman, and Tim Wicks bring a depth of experience and knowledge in both the healthcare and technology industries BOSTON–(BUSINESS WIRE)–Pear Therapeutics, Inc. (Nasdaq: PEAR), the leader in developing and commercializing software-based medicines called prescription digital therapeutics (PDTs), today announced the election of Paul Mango and Tim Wicks and the … [Read more…]

Flywheel to Serve as Research Platform for Understanding Pediatric Brain Development in Low- and Middle-Income Countries

Grant from Bill & Melinda Gates Foundation will fund research collaboration among 25 global sites MINNEAPOLIS–(BUSINESS WIRE)–Flywheel, the leading data management platform for biomedical research and collaboration, has received a grant from the Bill & Melinda Gates Foundation to support research on the neurodevelopmental health of children growing up in poverty and other adverse environments … [Read more…]

Antibe Therapeutics Announces Amendment to Warrant Terms

TORONTO–(BUSINESS WIRE)–Antibe Therapeutics Inc. (TSX: ATE, OTCQX: ATBPF) (the “Company“), a clinical stage company leveraging its hydrogen sulfide platform to develop next-generation safer therapies that target inflammation, announces that it is extending the expiry date (the “Warrant Extension”) and amending the exercise price (the “Amended Exercise Price”) of 3,117,957 common share purchase warrants (“Warrants”) of … [Read more…]

Mednow Beats Guidance & Achieves Record Q3 2022 Financial Results with 225% Q/Q Revenue Growth and 4,800% Y/Y Revenue Growth and Appoints Ali Reyhany CEO

Q3/22 revenue increased over 225% quarter-over-quarter, and more than 4,800% year-over-year; Mednow patient count increased by approximately 20% to ~23,000 in Q3 versus ~19,000 in Q2; In the 2022 calendar year, revenue is forecasted to range between C$42.5M and C$47.5M; approximately C$42M will come from its pharmacy services, while approximately C$3M will come from doctor … [Read more…]

Nanodropper Announces 800% Year Over Year Increase in Partnerships and Over 730 New Locations Nationwide Enabling a Reduction in Medical Waste and Lower Cost to Patients

Now available in eye clinics across 49 states and Puerto Rico, each new partnership increases access to Nanodropper’s value-based care solution for reducing the size of prescription eye drops while also extending the life of the medication ROCHESTER, Minn.–(BUSINESS WIRE)–#MedicalDevice—Nanodropper, a patient-centered, volume-reducing adaptor for eyedrop bottles, announces major growth metrics over the last 12 … [Read more…]

The Worldwide Clinical Trial Kits Industry is Expected to Reach $2.8 Billion by 2030 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Clinical Trial Kits Market Share, Size, Trends, Industry Analysis Report, By Service , By Phase , By Region; Segment Forecast, 2022 – 2030” report has been added to ResearchAndMarkets.com’s offering. The global clinical trial kits market is anticipated to grow up to USD 2.85 billion by 2030 according to a new study. The … [Read more…]

Enovis™, Formerly Branded DJO®, Introduces Arsenal Ankle Plating System™

A comprehensive ankle plating portfolio, designed with the proven technology of Arsenal Foot Plating System, expands offerings to address both tri-malleolar and intra-articular fracture patterns WILMINGTON, Del.–(BUSINESS WIRE)–DJO® is now part of the Enovis™ family.* Enovis Corporation, an innovation-driven medical technology growth company, announced today the launch of the Arsenal Ankle Plating System™. This system … [Read more…]

SHIONOGI SIGNS AGREEMENT WITH NHS ENGLAND TO BEGIN AN INNOVATIVE SUBSCRIPTION PAYMENT MODEL FOR REIMBURSEMENT OF ITS ANTIBIOTIC, FETCROJA®▼ (CEFIDEROCOL)

Shionogi and NHS England have signed an agreement to begin an innovative subscription payment model for reimbursement of cefiderocol in England which ‘de-links’ payment from volume of use1 Shionogi recognises the UK’s leadership role in introducing the world’s first fully ‘delinked’ pilot reimbursement model; pull incentives like this are an important step in making the … [Read more…]